Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Temporal trends in the prevalence of diabetic kidney disease in the United States.

de Boer IH, Rue TC, Hall YN, Heagerty PJ, Weiss NS, Himmelfarb J.

JAMA. 2011 Jun 22;305(24):2532-9. doi: 10.1001/jama.2011.861.

2.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Am J Kidney Dis. 2014 Oct;64(4):510-33. doi: 10.1053/j.ajkd.2014.08.001.

PMID:
25257325
3.

Antihypertensive agents for preventing diabetic kidney disease.

Lv J, Perkovic V, Foote CV, Craig ME, Craig JC, Strippoli GF.

Cochrane Database Syst Rev. 2012 Dec 12;12:CD004136. doi: 10.1002/14651858.CD004136.pub3. Review.

PMID:
23235603
4.

To RAS or not to RAS? The evidence for and cautions with renin-angiotensin system inhibition in patients with diabetic kidney disease.

St Peter WL, Odum LE, Whaley-Connell AT.

Pharmacotherapy. 2013 May;33(5):496-514. doi: 10.1002/phar.1232. Epub 2013 Apr 9. Review.

PMID:
23576066
5.

Diabetic kidney disease: a report from an ADA Consensus Conference.

Tuttle KR, Bakris GL, Bilous RW, Chiang JL, de Boer IH, Goldstein-Fuchs J, Hirsch IB, Kalantar-Zadeh K, Narva AS, Navaneethan SD, Neumiller JJ, Patel UD, Ratner RE, Whaley-Connell AT, Molitch ME.

Diabetes Care. 2014 Oct;37(10):2864-83. doi: 10.2337/dc14-1296.

6.

Diabetic Kidney Disease in Adolescents With Type 2 Diabetes: New Insights and Potential Therapies.

Bjornstad P, Cherney DZ, Maahs DM, Nadeau KJ.

Curr Diab Rep. 2016 Feb;16(2):11. doi: 10.1007/s11892-015-0708-0. Review.

7.

Renin-Angiotensin-Aldosterone system blockade in diabetic kidney disease: A critical and contrarian point of view.

Elrggal ME, Ahmed SM, El Nahas M.

Saudi J Kidney Dis Transpl. 2016 Nov-Dec;27(6):1103-1113. Review.

8.

Recent trends in the prevalence of chronic kidney disease: not the same old song.

Hsu RK, Powe NR.

Curr Opin Nephrol Hypertens. 2017 May;26(3):187-196. doi: 10.1097/MNH.0000000000000315. Review.

PMID:
28319485
9.

Diabetic kidney disease: from physiology to therapeutics.

Mora-Fernández C, Domínguez-Pimentel V, de Fuentes MM, Górriz JL, Martínez-Castelao A, Navarro-González JF.

J Physiol. 2014 Sep 15;592(18):3997-4012. doi: 10.1113/jphysiol.2014.272328. Epub 2014 Jun 6. Review.

10.

Clinical predictive factors in diabetic kidney disease progression.

Radcliffe NJ, Seah JM, Clarke M, MacIsaac RJ, Jerums G, Ekinci EI.

J Diabetes Investig. 2017 Jan;8(1):6-18. doi: 10.1111/jdi.12533. Epub 2016 Jun 8. Review.

11.

Update of pathophysiology and management of diabetic kidney disease.

Lin YC, Chang YH, Yang SY, Wu KD, Chu TS.

J Formos Med Assoc. 2018 Feb 24. pii: S0929-6646(17)30803-3. doi: 10.1016/j.jfma.2018.02.007. [Epub ahead of print] Review.

12.

Diabetic kidney disease in children and adolescents.

Afkarian M.

Pediatr Nephrol. 2015 Jan;30(1):65-74; quiz 70-1. doi: 10.1007/s00467-014-2796-5. Epub 2014 Mar 19. Review.

13.

Chronic kidney disease, diabetes, and hypertension: what's in a name?

Levey AS, Astor BC, Stevens LA, Coresh J.

Kidney Int. 2010 Jul;78(1):19-22. doi: 10.1038/ki.2010.115. Epub 2010 Apr 28. Review.

14.

Treatment of Diabetic Kidney Disease With Hypertension Control and Renin Angiotensin System Inhibition.

Patney V, Chaudhary K, Whaley-Connell A.

Adv Chronic Kidney Dis. 2018 Mar;25(2):158-165. doi: 10.1053/j.ackd.2017.11.002. Review.

PMID:
29580580
15.

Clinical therapeutic strategies for early stage of diabetic kidney disease.

Kitada M, Kanasaki K, Koya D.

World J Diabetes. 2014 Jun 15;5(3):342-56. doi: 10.4239/wjd.v5.i3.342. Review.

16.

JAK inhibition in the treatment of diabetic kidney disease.

Brosius FC, Tuttle KR, Kretzler M.

Diabetologia. 2016 Aug;59(8):1624-7. doi: 10.1007/s00125-016-4021-5. Epub 2016 Jun 22. Review.

17.

Diabetic kidney disease.

Thomas MC, Brownlee M, Susztak K, Sharma K, Jandeleit-Dahm KA, Zoungas S, Rossing P, Groop PH, Cooper ME.

Nat Rev Dis Primers. 2015 Jul 30;1:15018. doi: 10.1038/nrdp.2015.18. Review.

PMID:
27188921
18.

Novel avenues for drug discovery in diabetic kidney disease.

Breyer MD, Kretzler M.

Expert Opin Drug Discov. 2018 Jan;13(1):65-74. doi: 10.1080/17460441.2018.1398731. Epub 2017 Nov 16. Review.

PMID:
29145743
19.

Early detection of diabetic kidney disease: Present limitations and future perspectives.

Lin CH, Chang YC, Chuang LM.

World J Diabetes. 2016 Jul 25;7(14):290-301. doi: 10.4239/wjd.v7.i14.290. Review.

20.

Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Pichler R, Afkarian M, Dieter BP, Tuttle KR.

Am J Physiol Renal Physiol. 2017 Apr 1;312(4):F716-F731. doi: 10.1152/ajprenal.00314.2016. Epub 2016 Aug 24. Review.

Supplemental Content

Support Center